Promote Sponsor
verified SJR 2,066 · Q1 • database Scopus / SJR & Web of Science & DOAJ indexed
Journal of Headache and Pain
Italy · Springer-Verlag Italia s.r.l...
workspace_premium Q1 — Medicine (miscellaneous) verified Plan S Compliant visibility_off Single blind Peer Review lock_open Open Access · DOAJ Unclaimed

Journal of Headache and Pain

Journal of Headache and Pain is a journal indexed in SJR in Medicine (miscellaneous) and Neurology (clinical) with an H index of 97. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1507 €. The scope of the journal is focused on headache medicine, pain management. It has an SJR impact factor of 2,066 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,066.

Journal of Headache and Pain focuses its scope in these topics and keywords: headache, burden, cost, view, drugs, india, oxide, study, vasoconstriction, nitric, ...

ISSN: 1129-2369
Editorial: Springer-Verlag Italia s.r.l.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guía para Autores (Guidelines)
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
2,066 Q1
H-index 97
Tasa de Aceptación pie_chart
27% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
13 semanas
Campo Average_time_publication_weeks
Coste de Publicación (APC) payments
1.507 € Open Access
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science DOAJ

SJR Impact

2,066

H-index

97

Docs (year)

219

Docs 3y

467

Total refs

12322

Cites 3y

3260

Citable 3y

457

Cites/Doc 2y

7.57

Ref/Doc

56.26

Immediate OA

1507 €

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinical experience with triptans

View more

World Headache Alliance: raising headache awareness worldwide

View more

Epidemiology of migraine

View more

Electromyographical ischemic test, clinical symptoms related to neuromuscular hyperexcitability, and intra- and extracellular Mg++ levels in headache patients

View more

Dolichoectasia of the cavernous internal carotid artery: another cause for Raeder's syndrome

View more

Do changes of ANS in migraine subjects play a pathogenetic role?

View more

Do accompanying symptoms in women with migraine allow distinction between two separate patient groups?

View more

Discrepancies between European countries and USA and Canada in the availability of triptans and in their licensed clinical properties

View more

Disability in migraine patients:

View more

Disability and migraine: recent outcomes using an Italian version of MIDAS

View more

Comorbidities of migraine: a user-friendly overview

View more

Co-morbidity of migraine and epilepsy: a review of clinical features

View more
SHOW MORE ARTICLES

Cluster-like headache: literature review

View more

A patient with SUNCT syndrome responsive to sodium valproate

View more

Clinical considerations preliminary to application of the Italian Society for the Study of Headache's guidelines regarding migraine prophylactic treatment

View more

Chronic daily headache: how to manage it?

View more

Choice of open or percutaneous procedures in the surgical treatment of trigeminal neuralgia

View more

Changing of the guard at

View more

Can we objectively measure the human cost of disease?

View more

Burden of headache in Africa

View more

Brain-derived neurotrophic factor in cerebrospinal fluid of patients with chronic daily headache: relationship with nerve growth factor and glutamate levels

View more

Botulinum toxin type A in the

View more

Analgesic therapy for headache: consumption, appropriateness and costs

View more

An open-label pilot study on the

View more

FAQS